{
  "retracted": false,
  "timestamp": 1331078400000,
  "updates": [
    {
      "timestamp": 1585210676609,
      "identifier": {
        "doi": "10.1245/s10434-012-2228-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1245/s10434-011-2190-5"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132"
}
